Insights for Vertex Pharmaceuticals
NASDAQ: VRTX
06 - Growing & Well-Funded but Loss-Making

Today's Price
updated on:
455.22 (-3.14%)
Open 459.83 (-1.0%)
High (Upside %) 468.19 (2.85%)
Low (Downside %) 452.49 (0.6%)
P. Close 469.97 (-3.14%)
Open-High % 1.82%
Open-Low % 1.6%
Low-High % 3.47%
Active Buy Quantity 0
Active Sell Quantity 0
% Overtraded
Current Mood bearish
Previous Data
data from:
Open-High % 0.29%
Open-Low % 1.4%
Low-High % 1.71%
Open-Close % -0.13%
Low-Close % 1.28%
High-Close % 0.42%

VRTX is a Stock listed in the US on the NASDAQ under the ticker 'VRTX'

Company Profile

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

source:https://finance.yahoo.com/VRTX/profile

Predicted Prices
Key Low (open) Low (high) Close-Down (open) Close-Down (high) Close-Up (open) Close-Up (low) High (open) High (low)
Low Volatility 458.11
44.1% hit
461.92
55.44% hit
456.01
16.38% hit
466.66
43.5% hit
461.89
19.43% hit
454.24
45.56% hit
461.06
45.36% hit
458.63
55.44% hit
Average Volatility 453.51
32.49% hit
457.03
35.41% hit
452.81
14.19% hit
462.74
31.9% hit
467.0
13.93% hit
459.62
33.42% hit
466.24
31.1% hit
463.54
35.41% hit
High Volatility 445.99
3.65% hit
445.61
3.05% hit
447.56
3.32% hit
453.56
3.91% hit
474.44
3.32% hit
471.21
3.25% hit
476.81
3.32% hit
475.42
3.05% hit

VRTX's predicted prices using open from of 459.83 and data until date . Current Price is 455.22

Basic Stats
Market Cap-Display Market Cap-Actual Market Cap Enterprise Value-Display Enterprise Value-Actual Enterprise Value Trailing P/E Forward P/E PEG Ratio (5yr expected) Price/Sales Price/Book Enterprise Value/Revenue Enterprise Value/EBITDA Profit Margin Operating Margin Return on Assets Return on Equity Revenue-Display Revenue-Actual Revenue Quarterly Revenue Growth EBITDA-Display EBITDA-Actual EBITDA Diluted EPS Quarterly Earnings Growth Total Cash-Display Total Cash-Actual Total Cash Total Debt-Display Total Debt-Actual Total Debt Total Debt/Equity Current Ratio Operating Cash Flow-Display Operating Cash Flow-Actual Operating Cash Flow Levered Free Cash Flow-Display Levered Free Cash Flow-Actual Levered Free Cash Flow % Held by Insiders % Held by Institutions
113.49 B 113490000000.0 113.49 108.67 B 108670000000.0 108.67 31.73 23.92 1.15 10.73 7.26 10.23 209.9 -4.51% 40.82% 12.05% -2.98% 10.63 B 10630000000.0 10.63 11.60% 4.45 B 4450000000.0 4.45 -1.89 1.00% 6.52 B 6520000000.0 6.52 1.77 B 1770000000.0 1.77 0.11349999999999999 2.47 -840.0 mn -842600000.0 -0.84 3.06 B 3060000000.0 3.06 0.08% 95.91%

source:https://finance.yahoo.com/VRTX/key-statistics

Upside-Downside Spread
Key Weighted 5D 1M 3M 6M 1Y 3Y 10Y
Upside % (high) 10.46% 8.04% (491.805) 8.04% (491.805) 14.2% (519.88) 14.2% (519.88) 14.2% (519.88) 14.2% (519.88) 14.2% (519.88)
Downside % (low) 10.28% -1.93% (464.01) 12.74% (397.245) 17.0% (377.85) 17.0% (377.85) 17.0% (377.85) 50.51% (225.28) 84.3% (71.46)
Spread % 0.18% 9.97% -4.7% -2.79% -2.79% -2.79% -36.31% -70.1%

VRTX's price used for computing the stats is 455.22 as on date

Cumulative Return Percent
Key Today 5D 1M 3M 6M 1Y 3Y 10Y
Last Price-Trend PrevClose -3.14% -3.22% 11.49% -3.37% -8.17% 8.62% 86.76% 318.71%
Last Price 455.22 455.22 455.22 455.22 455.22 455.22 455.22 455.22
Trend-Previous Close 469.97 470.37 408.32 471.12 495.72 419.08 243.75 108.72

VRTX's symbol cumulative return percent is computed basis data from date

Return Velocity
5D 2W 1M 3M 6M 1Y
5D window
Metric Mean Median Stdev
Overall 6.28% 9.44% 5.07%
Up 8.22% 9.44% 3.26%
Down -0.29% -0.22% 0.32%
5D Opportunity: BUY-ACTIVE
returns: -3.22% (0.6%), p.close: 470.37
entry: 467.52, exit: 490.92, return: 5.0%
Metric Mean Median Stdev
Overall 4.82% 4.09% 4.04%
Up 6.05% 5.41% 3.4%
Down -0.33% -0.25% 0.4%
5D Opportunity: BUY-ACTIVE
returns: -3.22% (0.73%), p.close: 470.37
entry: 466.95, exit: 470.58, return: 0.78%
Metric Mean Median Stdev
Overall 3.87% 3.34% 2.99%
Up 4.58% 3.79% 2.76%
Down -0.36% -0.14% 0.49%
5D Opportunity: BUY-ACTIVE
returns: -3.22% (0.85%), p.close: 470.37
entry: 466.35, exit: 472.01, return: 1.21%
Metric Mean Median Stdev
Overall 0.23% 0.93% 5.61%
Up 2.94% 2.77% 2.79%
Down -2.51% -0.82% 4.11%
5D Opportunity: BUY-APPROACHING
returns: -3.22% (6.62%), p.close: 470.37
entry: 439.24, exit: 448.36, return: 2.08%
Metric Mean Median Stdev
Overall -0.04% 0.14% 4.62%
Up 2.42% 1.97% 2.4%
Down -2.19% -1.02% 3.25%
5D Opportunity: BUY-APPROACHING
returns: -3.22% (5.44%), p.close: 470.37
entry: 444.78, exit: 449.28, return: 1.01%
Metric Mean Median Stdev
Overall 0.31% 0.44% 3.81%
Up 2.11% 1.47% 2.2%
Down -1.66% -0.87% 2.54%
5D Opportunity: BUY-APPROACHING
returns: -3.22% (4.2%), p.close: 470.37
entry: 450.61, exit: 454.54, return: 0.87%
2W window
Metric Mean Median Stdev
Overall 8.83% 8.34% 3.41%
Up 10.11% 10.9% 2.78%
Down -0.39% -0.14% 0.6%
2W Opportunity:
returns: 2.55% (12.89%), p.close: 443.88
entry: 501.1, exit: 496.02, return: 1.01%
Metric Mean Median Stdev
Overall 6.35% 6.47% 3.84%
Up 7.09% 7.04% 3.91%
Down -0.69% -0.29% 0.88%
2W Opportunity:
returns: 2.55% (11.0%), p.close: 443.88
entry: 492.69, exit: 489.64, return: 0.62%
Metric Mean Median Stdev
Overall -0.03% 1.65% 7.66%
Up 4.5% 3.73% 3.85%
Down -4.13% -1.36% 5.48%
2W Opportunity:
returns: 2.55% (8.35%), p.close: 443.88
entry: 480.94, exit: 485.19, return: -0.88%
Metric Mean Median Stdev
Overall -0.29% -0.04% 6.0%
Up 3.78% 3.05% 3.25%
Down -3.51% -2.37% 4.17%
2W Opportunity:
returns: 2.55% (7.03%), p.close: 443.88
entry: 475.09, exit: 470.32, return: 1.0%
Metric Mean Median Stdev
Overall 0.44% 0.55% 5.2%
Up 3.41% 2.77% 3.12%
Down -2.63% -1.62% 3.35%
2W Opportunity:
returns: 2.55% (6.53%), p.close: 443.88
entry: 472.88, exit: 469.39, return: 0.74%
1M window
Metric Mean Median Stdev
Overall 3.3% 7.46% 12.55%
Up 8.6% 8.42% 8.2%
Down -7.13% -2.53% 7.09%
1M Opportunity: SELL-APPROACHING
returns: 11.49% (16.79%), p.close: 408.32
entry: 476.89, exit: 490.03, return: -2.76%
Metric Mean Median Stdev
Overall -1.84% -4.03% 9.7%
Up 6.61% 6.32% 5.66%
Down -7.51% -6.25% 5.59%
1M Opportunity: SELL-APPROACHING
returns: 11.49% (12.27%), p.close: 408.32
entry: 458.43, exit: 431.48, return: 5.88%
Metric Mean Median Stdev
Overall -1.4% -2.03% 7.18%
Up 5.3% 4.03% 4.5%
Down -5.86% -5.03% 4.55%
1M Opportunity: SELL-ACTIVE
returns: 11.49% (9.8%), p.close: 408.32
entry: 448.35, exit: 429.37, return: 4.23%
Metric Mean Median Stdev
Overall 0.47% -1.4% 7.19%
Up 5.41% 3.71% 4.87%
Down -4.29% -3.58% 3.9%
1M Opportunity: SELL-ACTIVE
returns: 11.49% (10.28%), p.close: 408.32
entry: 450.28, exit: 431.95, return: 4.07%

VRTX's symbol current price is 455.22 (-3.14%) as on . Yesterday's close was 469.97. It's return velocities are computed basis data from date .

Win Percent
Key Weighted 5D 1M 3M 6M 1Y 3Y
Open-High (> 1.0%) 48.04% 40.0% 54.55% 56.06% 46.97% 41.67% 43.52%
Open-Low (> 1.0%) 53.41% 60.0% 50.0% 50.0% 45.45% 42.06% 43.92%
Open-Close-Up (> 0.5%) 42.5% 40.0% 45.45% 45.45% 39.39% 34.92% 37.96%
Open-Close-Down (> 0.5%) 31.55% 40.0% 22.73% 28.79% 28.79% 30.16% 31.61%
Low-Close-Up (> 1.0%) 57.42% 60.0% 59.09% 54.55% 50.76% 43.25% 47.49%
High-Close-Down (> 1.0%) 39.01% 40.0% 36.36% 40.91% 39.39% 38.89% 39.15%

VRTX's symbol win percent is computed basis data from date